General description
INN
Rasburicase
ATC codes
Medicine type
Biological agent
EML status history
First added in 2021
(TRS
1035)
for
Tumour lysis syndrome
Wikipedia
DrugBank
Recommendations
Section
Supportive medicines
- Parenteral > General injections > IV: 1.5 mg in vial powder and solvent for solution; 7.5 mg in vial powder and solvent for solution
Indications